[Pharmacological prevention and treatment of diabetic nephropathy].
Aitio
M L
ML
Laakson saitaala, Helsinki, Finland.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy; D011453:Prostaglandins / Q000502:physiology; D011507:Proteinuria / Q000188:drug therapy; D012084:Renin-Angiotensin System / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D011453:Prostaglandins
Diabeettisen nefropatian farmakologinen ehkäisy ja hoito.